[Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D000990:Antithrombin III / Q000096:biosynthesis*; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D002994:Clofibrate / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D011725:Pyridines / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013468:Suloctidil / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D013988:Ticlopidine
D000925:Anticoagulants; D011725:Pyridines; D013876:Thiophenes; D004176:Dipyridamole; D000990:Antithrombin III; D002994:Clofibrate; D013988:Ticlopidine; D013442:Sulfinpyrazone; D013468:Suloctidil
Farmaci antiaggreganti piastrinici e cardiopatia ischemica: valutazione dell'effetto sull'aggregazione plastrinica e sull'antitrombina III.